Indonesia Ranked as World's Top E-Cigarette Consumer

Market by 2FIRSTS.ai
Jan.10.2024
Indonesia Ranked as World's Top E-Cigarette Consumer
Indonesia leads the world in e-cigarette consumption, with 25% of respondents admitting to using them, according to a survey.

According to Validnews, a news organization in Indonesia, Agus Dwi Susanto, the chairman of the Indonesian Association of Respiratory Disease Experts (PDPI), has stated that Indonesia is now the largest consumer of e-cigarettes in the world.

 

The statement refers to the results of the Statista Consumer Insights survey conducted from January to March 2023. As many as 25% of Indonesian respondents answered that they have used e-cigarettes at least once. This proportion is higher than that of Switzerland (16%), the United States (15%), and the United Kingdom (13%).

 

Angus DeVeyng, during an online media briefing held on January 9th, stated, "This is targeted towards adolescents."

 

Subsequently, he cited a study conducted by Friendship Hospital in 2021, revealing a societal shift from e-cigarettes to traditional cigarettes. A staggering 76.7% of respondents believe that e-cigarettes have lower nicotine content.

 

They also believe that e-cigarettes can be used as a nicotine replacement therapy. However, in reality, e-cigarettes do not meet the requirements for smoking cessation treatment. This is because they fail to meet eight fundamental principles.

 

Firstly, individuals who participate in NRT (Nicotine Replacement Therapy) must cease smoking. However, in Indonesia, the use of e-cigarettes actually encourages a significant number of dual users, who are both e-cigarette consumers and traditional smokers.

 

Research data from Dr. Hamka, a professor at Uhamka University in Indonesia, reveals this point. Subsequently, research records from the University of Indonesia (UI) indicate that 61.5% of students are dual users.

 

Furthermore, individuals undergoing NRT treatment must be supervised by healthcare professionals. However, in Indonesia, the use of e-cigarettes for smoking cessation is carried out without any supervision.

 

Third, people receiving NRT treatment need to gradually reduce their nicotine dosage until completely quitting nicotine products. However, e-cigarette users in Indonesia do not require dosage reduction.

 

Fourth, non-smoking treatments typically last for three months before evaluation. In Indonesia, however, the majority of people actually continue to use e-cigarettes even after they quit using traditional cigarettes.

 

Agus, a professor of pulmonary disease and respiratory medicine at the International University of Indonesia, also stated that the most effective method for quitting smoking is to strengthen one's commitment. If the commitment is strong, healthcare workers are better able to provide assistance.

 

Forms of assistance can include smoking cessation medications, which have a success rate of 30% - 50%. If patients find it difficult to quit smoking using medication, non-pharmaceutical help such as hypnotherapy, psychotherapy, acupuncture, and medical rehabilitation may be required.

 

He stated that, "In general circumstances, the success rate can nearly reach 60-70% with the additional treatment options available, both through medication and non-medication."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23